pre-miRNA Information | |
---|---|
pre-miRNA | mmu-mir-674 |
Genomic Coordinates | chr2: 117185127 - 117185226 |
Synonyms | Mirn674, mmu-mir-674, Mir674 |
Description | Mus musculus miR-674 stem-loop |
Comment | Landgraf et al. show that the 5' miRNA product is the predominant one . |
RNA Secondary Structure |
Mature miRNA Information | |
---|---|
Mature miRNA | mmu-miR-674-5p |
Sequence | 25| GCACUGAGAUGGGAGUGGUGUA |46 |
Evidence | Experimental |
Experiments | MPSS |
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | Med22 | ||||||||||||||||||||
Synonyms | AW212655, AW558812, Surf-5, Surf5 | ||||||||||||||||||||
Description | mediator complex subunit 22 | ||||||||||||||||||||
Transcript | NM_011513 | ||||||||||||||||||||
Other Transcripts | NM_001033908 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on Med22 | |||||||||||||||||||||
3'UTR of Med22 (miRNA target sites are highlighted) |
>Med22|NM_011513|3'UTR 1 GGCTGGACTGCCATGCAGGTGCTGCCTGCTGCCTGCCCAGACCAGCTAGGGCCTGCAATGGCCTTGTGTTTTTCCAAGTT 81 CTCCTTGGCAGCAGAGCCCCTGACTAGCTCGTTTGACGGACAGACAGTCATAGCCAGCCACCAGCAGGGGCCCAGGCCTT 161 CCCTTCAATGAAGAGGGATGAAAACACAGGACTTGGTTGTGTGTCAACGGCTGTGGCCAGAAAAGGGTATCCCCCAGGGG 241 GCGAGGAAGCCCTCCAGGGCAACACAGTCTCTGTCTTACTGCTTTAAATCTCTTGTCTGTCTAGACAGTTTAGTCAAGGC 321 TGGATTGGCCCCTTGTGGCCTTCCAGGTCTCTAACGACGTTCACTTTCTGGGACAGCCCTGCCTACTGCTTGCTCAGAGA 401 TTCAGTTCCATGTGAATGTCATCAGACTCACAGTGGAGAGGTGGGATGGGGGAGGGGTAAGGAACTCAAGCAGGGTGGCT 481 TTGACTCCTGGGCCCAAGATACCTGGATGTCAGCTCGGCCTTATTCATGGAGCTGGAGTCTCCTGGTGTCAGACCTATGT 561 TAGTCTCAGAGGATAGCAGCAGGCAGGATCTGTCACATAGCTCTCTACAGGGCCACTTAGAATGTTGATACCTGAAACTT 641 TCTGATCCAGAGAGGCCTTGAGAAATCAAGAGTCCAGTGTAAAATATGTCGTCGGAACCGGGCTGGAGAATGGAGGCCTT 721 GCCCCACCCCATTAGCTTGAAGTTAAGGTTCCGGTCAGCAGCACCCTGCCTGACTCCCCCTGGTGGTAGGTTTGCTCCTG 801 CTGCTGCTGCACAGAAGCTGCAGTCAACTACAGATGTCCAGTGCTGCAGTGGACATCTTGTTCCCATCTTAGACTCAGTG 881 TCACTGCCAAGCTTCAGTAGTTCTAAAGTTCTCCAGAGAGTTCTGGGGTTATCTTTGGTCTCAGTGTTCATCAGCTTAGC 961 AGAAAAGTGGGAGTATCTACTGTACCCCAAAGTGGCAGAGACTTAGACCAACCCAGGGTGAGTTCCTCACATCTTCCTGT 1041 CACTACCTTGTAGTACTTCAAGGACACTTGAGCGGATGAGTACTGGGACAGTGACTCAGTCCTGTACAAGGGTTGAGGGG 1121 ATAAATTGCTCAGATAGGAACCCAGAGTGCTGGGTTTCCAAAGCCTCGGCCCCTCTGCATCACGTGCATACGTTTCTGGG 1201 ATGATCTGTGTCCTCTTTGGGCAATCACCTCTCTCATATTCCTCATGGTAAAGCAGCTGCCCCATGCCTAGGAATTTCCT 1281 TAAATGGCAGAGTTCTTCGGTAGGTGAGGCAGTAGGTTTTGTCTGCCCCTATCAGCCTCCTGCCCACACCACCACCAGTT 1361 GCCCAGCTTCCCCTCTGCATGGCTACTCTTGCCTGTATACGAACTGCTTGCTCTTTCTGGCTTTGCCTTCCCTCCATTCT 1441 CCTGGGGATGCTACTCCCTTTGTCTTGGGTAGTTCTGCGAGAGACTGCTGGGGACAGGCATGGGAGAAAGCTAGGGCCTT 1521 GTGCATATTAGACAGCTGTAGAAACAGATGTGGTCCAAGTAGCCACTGCTATGACCACTGAGGCATTGTGCTTGCCTCCT 1601 CCTGTCTCTGGCTTTCCCTGTGTAATGTAAGGAAATGGAATGTGTAAAGCCTGGGGCTTAGAGCTGTAGAGCTAGAGTAG 1681 TGGTATATAGAGAAATGCTCAGACCTGTATTGCTGACTGTTACCCAGTTAGGCCAGGACCCTGTAGGGATGGAAACAGGT 1761 CTGCCACCAGGAGCTCTTTGTAAAGTCTCATCACTACCCTACTGGTAAGGGATGGGTAACAGGTAGAGGCTGATAGGAAC 1841 AAGGAGAGTCCTATGTGTCAAGAAGGACCCATGGGGACAGTTTGCCTAAGTCACATGGCCTGTTGACACCACCTTTCTTT 1921 GGATGCAAGAGTGGCCAGAACCGCTTAGCAGAGGGGCCAGCACAGAGGAGAAGAAGGGGAGGCAGTCAGGTGATGTTCAT 2001 TTCTTAACTCTGCATCTGTCTTGCTTTCCCCTCCCTGGCTTTCCTCTGCCTGCTCCTGTCACTCCTGGGGGTTTCTTGTG 2081 GTGGCAAAGCTCAAGTCTCTGCGAAGCTAATGACCTGCCTCTGTGTGAAGCTTACTGGAGGCTGGACCTCGACGCAGATT 2161 CTGCTGATGGCCTCTCAGCCCCTCTTCTGGCGTCCCCGGAGACTGGTGCTGGTCCCTTACAGTCTGCAGCCCCTGTCCAC 2241 TCCCATGGTGGTGGCCCTGGCCCTACAGAACACACCTGAGCCTCTTGGGGTACCATCGCAGGGTAGCCCTCCCTAGGGCC 2321 TAGTTTATCAGAAAGGAAGTGCTGTGGATACCCAGCACAGCCTAGCTTTTTTCAGTTTTAGCTCCCTTGGGGACTTTGGG 2401 ATCAGGAGCCACTGTAGCCTCAGGAACCTGTCCAGGCCAGGGCCAGTTCCCCGTGATGGTTGGGGAATGCTGTCCAGTTA 2481 TTTACAGCAGGTGGCTCCCTTCCTGACTGCCAGTGGAAGTTTGTCCCATTGAAGACCTTGAATAGGGAGGGTGGTTGGTG 2561 ATAGGAAGACAGCCTCAGTTTGTTTAGAATTGTGAGGTATTCAGTGGACCTTAGTCAAGTCCAGTTACCCATCCTTAGGT 2641 TCAGGTTCTATAGAGAGCCCTGTCCACTGCCTGCTGCCTGGAGCATAAATGTCTCTGCCACAGCTGACTGTCCAAGATTG 2721 TGTGAGAGGCAGCTAGCCAGGGTGTCTTCCTGGATTCTCCCACCATTTCCTTCTGCTACTTTTGAGATGAGACTGTTGAA 2801 TAAAACATTAGCTTTT Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | CD4+ T cells (C57BL/6) | ||||||
Disease | MIMAT0003740 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"HITS-CLIP data was present in GSM1013581. RNA binding protein: AGO2. Condition:CD4+ T cells
... - Loeb GB; Khan AA; Canner D; Hiatt JB; et al., 2012, Molecular cell. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Loeb GB; Khan AA; Canner D; Hiatt JB; et al. - Molecular cell, 2012
MicroRNAs (miRNAs) are essential components of gene regulation, but identification of miRNA targets remains a major challenge. Most target prediction and discovery relies on perfect complementarity of the miRNA seed to the 3' untranslated region (UTR). However, it is unclear to what extent miRNAs target sites without seed matches. Here, we performed a transcriptome-wide identification of the endogenous targets of a single miRNA-miR-155-in a genetically controlled manner. We found that approximately 40% of miR-155-dependent Argonaute binding occurs at sites without perfect seed matches. The majority of these noncanonical sites feature extensive complementarity to the miRNA seed with one mismatch. These noncanonical sites confer regulation of gene expression, albeit less potently than canonical sites. Thus, noncanonical miRNA binding sites are widespread, often contain seed-like motifs, and can regulate gene expression, generating a continuum of targeting and regulation.
LinkOut: [PMID: 23142080]
|
94 mmu-miR-674-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT577119 | Prps2 | phosphoribosyl pyrophosphate synthetase 2 | 1 | 3 | ||||||||
MIRT579212 | Ccdc25 | coiled-coil domain containing 25 | 1 | 4 | ||||||||
MIRT580735 | Srp72 | signal recognition particle 72 | 1 | 2 | ||||||||
MIRT581673 | Ppp2r2c | protein phosphatase 2, regulatory subunit B, gamma | 1 | 1 | ||||||||
MIRT582930 | Il15ra | interleukin 15 receptor, alpha chain | 1 | 1 | ||||||||
MIRT584530 | Bzrap1 | TSPO associated protein 1 | 1 | 1 | ||||||||
MIRT584648 | Bach2 | BTB and CNC homology, basic leucine zipper transcription factor 2 | 1 | 1 | ||||||||
MIRT586666 | Mbp | myelin basic protein | 1 | 2 | ||||||||
MIRT588993 | Rpl7l1 | ribosomal protein L7-like 1 | 1 | 1 | ||||||||
MIRT589588 | Magt1 | magnesium transporter 1 | 1 | 1 | ||||||||
MIRT590893 | Tmem69 | transmembrane protein 69 | 1 | 2 | ||||||||
MIRT590965 | Slfn5 | schlafen 5 | 1 | 2 | ||||||||
MIRT591089 | Pola2 | polymerase (DNA directed), alpha 2 | 1 | 2 | ||||||||
MIRT591253 | Loxl2 | lysyl oxidase-like 2 | 1 | 2 | ||||||||
MIRT591405 | Churc1 | churchill domain containing 1 | 1 | 2 | ||||||||
MIRT591425 | Casc4 | cancer susceptibility candidate 4 | 1 | 2 | ||||||||
MIRT591686 | Slc23a1 | solute carrier family 23 (nucleobase transporters), member 1 | 1 | 2 | ||||||||
MIRT591985 | A230046K03Rik | WASH complex subunit 4 | 1 | 2 | ||||||||
MIRT593044 | Ogdh | oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) | 1 | 2 | ||||||||
MIRT593330 | Ddx3x | DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 3, X-linked | 1 | 1 | ||||||||
MIRT594701 | Anks1b | ankyrin repeat and sterile alpha motif domain containing 1B | 1 | 1 | ||||||||
MIRT595566 | Sh3rf3 | SH3 domain containing ring finger 3 | 1 | 1 | ||||||||
MIRT595693 | Pcsk6 | proprotein convertase subtilisin/kexin type 6 | 1 | 1 | ||||||||
MIRT595863 | Myh10 | myosin, heavy polypeptide 10, non-muscle | 1 | 1 | ||||||||
MIRT596037 | Ubp1 | upstream binding protein 1 | 1 | 1 | ||||||||
MIRT596075 | Ywhag | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide | 1 | 1 | ||||||||
MIRT596182 | Med22 | mediator complex subunit 22 | 1 | 1 | ||||||||
MIRT596482 | Zyg11b | zyg-ll family member B, cell cycle regulator | 1 | 1 | ||||||||
MIRT596495 | Zfp935 | zinc finger protein 935 | 1 | 1 | ||||||||
MIRT596811 | Tyk2 | tyrosine kinase 2 | 1 | 1 | ||||||||
MIRT596873 | Tspan15 | tetraspanin 15 | 1 | 1 | ||||||||
MIRT597076 | Tbc1d24 | TBC1 domain family, member 24 | 1 | 1 | ||||||||
MIRT597180 | Spc24 | SPC24, NDC80 kinetochore complex component, homolog (S. cerevisiae) | 1 | 1 | ||||||||
MIRT597235 | Slc7a14 | solute carrier family 7 (cationic amino acid transporter, y+ system), member 14 | 1 | 1 | ||||||||
MIRT597281 | Slc22a15 | solute carrier family 22 (organic anion/cation transporter), member 15 | 1 | 1 | ||||||||
MIRT597347 | Scd3 | stearoyl-coenzyme A desaturase 3 | 1 | 1 | ||||||||
MIRT597359 | Sap18 | Sin3-associated polypeptide 18 | 1 | 1 | ||||||||
MIRT597446 | Rin1 | Ras and Rab interactor 1 | 1 | 1 | ||||||||
MIRT597514 | Rbbp4 | retinoblastoma binding protein 4, chromatin remodeling factor | 1 | 1 | ||||||||
MIRT597557 | Rab33b | RAB33B, member RAS oncogene family | 1 | 1 | ||||||||
MIRT597808 | Pla2g4b | phospholipase A2, group IVB (cytosolic) | 1 | 1 | ||||||||
MIRT597974 | Nup133 | nucleoporin 133 | 1 | 1 | ||||||||
MIRT598205 | Mpv17l | Mpv17 transgene, kidney disease mutant-like | 1 | 1 | ||||||||
MIRT598257 | Mfsd2b | major facilitator superfamily domain containing 2B | 1 | 1 | ||||||||
MIRT598574 | Irak1 | interleukin-1 receptor-associated kinase 1 | 1 | 1 | ||||||||
MIRT598860 | Gm10778 | predicted gene 10778 | 1 | 1 | ||||||||
MIRT599029 | Fam177a | family with sequence similarity 177, member A | 1 | 1 | ||||||||
MIRT599181 | Dennd5b | DENN/MADD domain containing 5B | 1 | 1 | ||||||||
MIRT599224 | Dcaf4 | DDB1 and CUL4 associated factor 4 | 1 | 1 | ||||||||
MIRT599261 | D3Ertd254e | DNA segment, Chr 3, ERATO Doi 254, expressed | 1 | 1 | ||||||||
MIRT599278 | Cyp2e1 | cytochrome P450, family 2, subfamily e, polypeptide 1 | 1 | 1 | ||||||||
MIRT599286 | Cxcr2 | chemokine (C-X-C motif) receptor 2 | 1 | 1 | ||||||||
MIRT599294 | Cx3cr1 | chemokine (C-X3-C motif) receptor 1 | 1 | 1 | ||||||||
MIRT599328 | Comt | catechol-O-methyltransferase | 1 | 1 | ||||||||
MIRT599355 | Commd7 | COMM domain containing 7 | 1 | 1 | ||||||||
MIRT599488 | Ccr9 | chemokine (C-C motif) receptor 9 | 1 | 1 | ||||||||
MIRT599583 | Brip1 | BRCA1 interacting protein C-terminal helicase 1 | 1 | 1 | ||||||||
MIRT599647 | Banp | BTG3 associated nuclear protein | 1 | 1 | ||||||||
MIRT599683 | Arl16 | ADP-ribosylation factor-like 16 | 1 | 1 | ||||||||
MIRT599726 | Ankfy1 | ankyrin repeat and FYVE domain containing 1 | 1 | 1 | ||||||||
MIRT600098 | 1700047I17Rik2 | RIKEN cDNA 1700047I17 gene 2 | 1 | 1 | ||||||||
MIRT601167 | Atrn | attractin | 1 | 1 | ||||||||
MIRT601187 | Asxl2 | additional sex combs like 2 (Drosophila) | 1 | 1 | ||||||||
MIRT601347 | Zfp202 | zinc finger protein 202 | 1 | 1 | ||||||||
MIRT601378 | Wdr89 | WD repeat domain 89 | 1 | 1 | ||||||||
MIRT601554 | Tapbpl | TAP binding protein-like | 1 | 1 | ||||||||
MIRT601574 | Ssr1 | signal sequence receptor, alpha | 1 | 1 | ||||||||
MIRT601739 | Rbm34 | RNA binding motif protein 34 | 1 | 1 | ||||||||
MIRT601844 | Polr2l | polymerase (RNA) II (DNA directed) polypeptide L | 1 | 1 | ||||||||
MIRT601894 | Pbld1 | phenazine biosynthesis-like protein domain containing 1 | 1 | 1 | ||||||||
MIRT601949 | Nol3 | nucleolar protein 3 (apoptosis repressor with CARD domain) | 1 | 1 | ||||||||
MIRT602826 | AK010878 | GON7, KEOPS complex subunit homolog | 1 | 1 | ||||||||
MIRT602859 | Rmi2 | RecQ mediated genome instability 2 | 1 | 1 | ||||||||
MIRT602916 | 1700016D06Rik | RIKEN cDNA 1700016D06 gene | 1 | 1 | ||||||||
MIRT603001 | Myo1c | myosin IC | 1 | 1 | ||||||||
MIRT603576 | Ppm1k | protein phosphatase 1K (PP2C domain containing) | 1 | 1 | ||||||||
MIRT603581 | Ppil4 | peptidylprolyl isomerase (cyclophilin)-like 4 | 1 | 1 | ||||||||
MIRT603702 | Nip7 | NIP7, nucleolar pre-rRNA processing protein | 1 | 1 | ||||||||
MIRT603710 | Naip5 | NLR family, apoptosis inhibitory protein 5 | 1 | 1 | ||||||||
MIRT603942 | H2-T23 | histocompatibility 2, T region locus 23 | 1 | 1 | ||||||||
MIRT604103 | Dph5 | diphthamide biosynthesis 5 | 1 | 1 | ||||||||
MIRT604202 | Cpne9 | copine family member IX | 1 | 1 | ||||||||
MIRT604229 | Clca2 | chloride channel accessory 3A2 | 1 | 1 | ||||||||
MIRT604242 | Cflar | CASP8 and FADD-like apoptosis regulator | 1 | 1 | ||||||||
MIRT604392 | Aipl1 | aryl hydrocarbon receptor-interacting protein-like 1 | 1 | 1 | ||||||||
MIRT604542 | Ypel2 | yippee-like 2 (Drosophila) | 1 | 1 | ||||||||
MIRT605321 | Zfp605 | zinc finger protein 605 | 1 | 1 | ||||||||
MIRT605421 | T2 | brachyury 2 | 1 | 1 | ||||||||
MIRT605424 | Synrg | synergin, gamma | 1 | 1 | ||||||||
MIRT605630 | Mfsd11 | major facilitator superfamily domain containing 11 | 1 | 1 | ||||||||
MIRT605750 | Exosc2 | exosome component 2 | 1 | 1 | ||||||||
MIRT605832 | Cenpf | centromere protein F | 1 | 1 | ||||||||
MIRT606053 | Zfp607 | zinc finger protein 607A | 1 | 1 | ||||||||
MIRT606349 | Lcmt2 | leucine carboxyl methyltransferase 2 | 1 | 1 |
miRNA-Drug Associations | |||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|